Estimates and Trends of the Global Burden of NASH-Related Liver Cancer Attributable to High Fasting Plasma Glucose in 1990–2019: Analysis of Data From the 2019 Global Burden of Disease Study

In the present study, we aimed to assess the burden of NASH-related liver cancer attributable to hyperglycemia, using estimates derived from epidemiological studies. We also aimed to evaluate the relative roles of the sociodemographic index (SDI) and age in the observed trend of hyperglycemia-induced NASH-related liver cancer burden.